These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 19179884

  • 1. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.
    Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW.
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):209-15. PubMed ID: 19179884
    [Abstract] [Full Text] [Related]

  • 2. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE.
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M.
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [Abstract] [Full Text] [Related]

  • 4. Total parenteral nutrition in patients with short bowel syndrome.
    Ekema G, Milianti S, Boroni G.
    Minerva Pediatr; 2009 Jun; 61(3):283-91. PubMed ID: 19461572
    [Abstract] [Full Text] [Related]

  • 5. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
    Burns DL, Gill BM.
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
    [Abstract] [Full Text] [Related]

  • 6. Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome.
    Botha JF, Grant WJ, Torres C, Iverson AK, Sudan DL, Shaw BW, Langnas AN.
    Liver Transpl; 2006 Jul; 12(7):1062-6. PubMed ID: 16710856
    [Abstract] [Full Text] [Related]

  • 7. The use of Omegaven in treating parenteral nutrition-associated liver disease.
    Park KT, Nespor C, Kerner J.
    J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
    [Abstract] [Full Text] [Related]

  • 8. Parenteral but not enteral omega-3 fatty acids (Omegaven) modulate intestinal regrowth after massive small bowel resection in rats.
    Sukhotnik I, Shany A, Bashenko Y, Hayari L, Chemodanov E, Mogilner J, Coran AG, Shaoul R.
    JPEN J Parenter Enteral Nutr; 2010 Apr; 34(5):503-12. PubMed ID: 20852178
    [Abstract] [Full Text] [Related]

  • 9. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?
    Diamond IR, Pencharz PB, Wales PW.
    Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570
    [Abstract] [Full Text] [Related]

  • 10. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?
    Nasr A, Diamond IR, de Silva NT, Wales PW.
    J Pediatr Surg; 2010 May; 45(5):980-6. PubMed ID: 20438939
    [Abstract] [Full Text] [Related]

  • 11. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, Carroll J, Jan DM.
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [Abstract] [Full Text] [Related]

  • 12. Isolated liver transplantation in pediatric short bowel syndrome: is there a role?
    Diamond IR, Wales PW, Grant DR, Fecteau A.
    J Pediatr Surg; 2006 May; 41(5):955-9. PubMed ID: 16677892
    [Abstract] [Full Text] [Related]

  • 13. Isolated liver and multivisceral transplantation for total parenteral nutrition-related end-stage liver disease.
    Nathan JD, Rudolph JA, Kocoshis SA, Alonso MH, Ryckman FC, Tiao GM.
    J Pediatr Surg; 2007 Jan; 42(1):143-7. PubMed ID: 17208555
    [Abstract] [Full Text] [Related]

  • 14. The use of conjugated hyperbilirubinemia greater than 100 micromol/L as an indicator of irreversible liver disease in infants with short bowel syndrome.
    Nasr A, Avitzur Y, Ng VL, De Silva N, Wales PW.
    J Pediatr Surg; 2007 Feb; 42(2):359-62. PubMed ID: 17270549
    [Abstract] [Full Text] [Related]

  • 15. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.
    Xu Z, Li Y, Wang J, Wu B, Li J.
    Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955
    [Abstract] [Full Text] [Related]

  • 16. Survival rate and prognostic factors in patients with intestinal failure.
    Vantini I, Benini L, Bonfante F, Talamini G, Sembenini C, Chiarioni G, Maragnolli O, Benini F, Capra F.
    Dig Liver Dis; 2004 Jan; 36(1):46-55. PubMed ID: 14971815
    [Abstract] [Full Text] [Related]

  • 17. Neonatal short bowel syndrome: a cohort study.
    Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM.
    J Pediatr Surg; 2005 May; 40(5):755-62. PubMed ID: 15937809
    [Abstract] [Full Text] [Related]

  • 18. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants.
    Javid PJ, Collier S, Richardson D, Iglesias J, Gura K, Lo C, Kim HB, Duggan CP, Jaksic T.
    J Pediatr Surg; 2005 Jun; 40(6):1015-8. PubMed ID: 15991188
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease.
    Taha AM, Sharif K, Johnson T, Clarke S, Murphy MS, Gupte GL.
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):547-51. PubMed ID: 22167020
    [Abstract] [Full Text] [Related]

  • 20. Nutritional management of infants with short bowel syndrome.
    Wessel JJ, Kocoshis SA.
    Semin Perinatol; 2007 Apr; 31(2):104-11. PubMed ID: 17462495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.